Previous studies have reported the presence of CD86 (B7.2) costimulatory molecule on endothelial cells (ECs) and recent data have shown that CTLA4-Ig (abatacept), used as a biological agent in rheumatoid arthritis, interacts with CD86 expressed on different cells involved in synovitis. Therefore, the effects of CTLA4-Ig/CD86 interaction on VEGFR-2 (vascular endothelial growth factor receptor 2) and ICAM1 expression, were evaluated in cultured ECs.

CTLA4-Ig/CD86 interactions in cultured human endothelial cells: effects on VEGFR-2 and ICAM1 expression

CUTOLO, MAURIZIO;MONTAGNA, PAOLA;SOLDANO, STEFANO;CONTINI, PAOLA;PAOLINO, SABRINA;PIZZORNI, CARMEN;SERIOLO, BRUNO;SULLI, ALBERTO;BRIZZOLARA, RENATA
2015

Abstract

Previous studies have reported the presence of CD86 (B7.2) costimulatory molecule on endothelial cells (ECs) and recent data have shown that CTLA4-Ig (abatacept), used as a biological agent in rheumatoid arthritis, interacts with CD86 expressed on different cells involved in synovitis. Therefore, the effects of CTLA4-Ig/CD86 interaction on VEGFR-2 (vascular endothelial growth factor receptor 2) and ICAM1 expression, were evaluated in cultured ECs.
File in questo prodotto:
File Dimensione Formato  
Clin Exp Rheumatol 2015;33;250-4. CTLA4 interactions in cultured .pdf

accesso chiuso

Descrizione: articolo su rivista
Tipologia: Documento in versione editoriale
Dimensione 663.86 kB
Formato Adobe PDF
663.86 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11567/812634
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 10
social impact